ScholarLens Back to search
2020•PancreatologyRequires access

Characterization of the germline and somatic mutation profile in familial pancreatic cancer reveals pathogenic germline variants and potentially druggable somatic mutations.

Julie Earl, María E. Castillo, Emma Barreto, Mercedes Rodríguez-Garrote, Vanessa Pachón, Reyes Ferreiro, María Luisa Villamayor, Núria Malats, Gloria Muñoz, Alfredo Carrato

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Somatic cell, Germline, Germline mutation, Medicine, Genetics, Druggability, Mutation, Cancer research

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Characterization of the germline and somatic mutation profile in familial pancreatic cancer reveals pathogenic germline variants and potentially druggable somatic mutations. — Research Paper | ScholarLens